{
  "id": "sequoia:iambic-therapeutics",
  "sequoia_id": "345",
  "name": "Iambic Therapeutics",
  "slug": "iambic-therapeutics",
  "description": "Iambic Therapeutics tackles challenging design problems in drug discovery with its physics-based AI platform. Its automated data pipelines help refine target profiles for drug candidates and enable high-throughput chemistry and biology to rapidly generate small-molecule therapeutics.",
  "website": "https://www.iambic.ai/",
  "socials": {
    "twitter": "https://twitter.com/iambic_ai",
    "linkedin": "https://www.linkedin.com/company/iambic-ai/"
  },
  "categories": [
    "ai",
    "healthcare"
  ],
  "current_stage": "early",
  "first_partnered_year": 2021,
  "partners": [
    "bill-coughran"
  ],
  "primary_partner": "bill-coughran",
  "milestones": {
    "founded_year": 2019,
    "partnered_year": 2021,
    "ipo_year": null,
    "acquired_year": null
  },
  "team": [
    {
      "name": "Tim Cernak",
      "role": null
    },
    {
      "name": "Fred Manby",
      "role": null
    },
    {
      "name": "Thomas Miller",
      "role": null
    },
    {
      "name": "Sarah Trice",
      "role": null
    }
  ],
  "why_partnered": null,
  "source_urls": {
    "directory": "https://sequoiacap.com/our-companies/",
    "profile": "https://sequoiacap.com/companies/iambic-therapeutics/"
  }
}
